Abstract
1 Peptide 401, a potent mast cell degranulating factor from bee venom, substantially inhibited the oedema provoked by subplantar injection of carrageenin or intra-articular injection of turpentine in the rat. The ED50 of 401 was c. 0.1 mg/kg. The anti-inflammatory effect was assessed by measurement of the increased 125I-albumin content of an injected site in comparison with an uninjected contralateral site.
2 Peptide 401 also suppressed the increased vascular permeability due to intradermal injection of various smooth muscle spasmogens (histamine, bradykinin, 5-hydroxytryptamine (5-HT), and prostaglandins).
3 Other comparable mast cell degranulating agents (48/80 and melittin) showed little evidence of anti-inflammatory activity when tested at comparable dosage on turpentine arthritis and carrageenin oedema.
4 The anti-inflammatory effects were not abolished by pretreatment with mepyramine and methysergide, which abolished the increased vascular permeability produced by local injection of 401.
5 The anti-inflammatory action of 401 was not affected by regional denervation or pretreatment with phenoxybenzamine, and was reduced but not abolished by adrenalectomy.
6 Measurement of skin temperature, fractional extraction of 86Rb and blood flow in perfused mesentery gave no evidence that the anti-inflammatory action of 401 was due to reduced tissue perfusion.
7 It is concluded that 401 may exert its anti-inflammatory action directly by making the vascular endothelium anergic to phlogistic stimuli.
Full text
PDF![383](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/3672dca9da97/brjpharm00537-0067.png)
![384](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/8590939d66ab/brjpharm00537-0068.png)
![385](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/ef2a6c968dbb/brjpharm00537-0069.png)
![386](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/6746020a2893/brjpharm00537-0070.png)
![387](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/6897ca823002/brjpharm00537-0071.png)
![388](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/6d9bd0033296/brjpharm00537-0072.png)
![389](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/9174f3226a0c/brjpharm00537-0073.png)
![390](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/4e7b54b08e29/brjpharm00537-0074.png)
![391](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/2268c0a380aa/brjpharm00537-0075.png)
![392](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1eb1/1776661/d3dee84b09ce/brjpharm00537-0076.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Billingham M. E., Morley J., Hanson J. M., Shipolini R. A., Vernon C. A. Letter: An anti-inflammatory peptide from bee venom. Nature. 1973 Sep 21;245(5421):163–164. doi: 10.1038/245163a0. [DOI] [PubMed] [Google Scholar]
- Breithaupt H., Habermann E. Mastzelldegranulierendes Peptid (MCD-Pepid) aus Bienengift: Isolierung, biochemische und pharmakologische Eigenschaften. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1968;261(3):252–270. [PubMed] [Google Scholar]
- DAVIES G. E., LOWE J. S. PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM. Br J Pharmacol Chemother. 1963 Dec;21:491–499. doi: 10.1111/j.1476-5381.1963.tb02017.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Di Rosa M., Giroud J. P., Willoughby D. A. Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971 May;104(1):15–29. doi: 10.1002/path.1711040103. [DOI] [PubMed] [Google Scholar]
- Ercoli N., Arbona J., Tabernero E. Anti-inflammatory properties of alkyl-pseudothioureas with antibacterial and antifungal activity. Proc Soc Exp Biol Med. 1971 Apr;136(4):1328–1331. doi: 10.3181/00379727-136-35485. [DOI] [PubMed] [Google Scholar]
- Habermann E., Reiz K. G. Zur Biochemie der Bienengiftpeptide Melittin und Apamin. Biochem Z. 1965 Nov 15;343(2):192–203. [PubMed] [Google Scholar]
- Haux P. Die Aminosäurensequenz von MCD-Peptid, einem spezifisch Mastzellen-degranulierenden Peptid aus Bienengift. Hoppe Seylers Z Physiol Chem. 1969 May;350(5):536–546. [PubMed] [Google Scholar]
- Wade D. N., Beilin L. J. Vascular resistance in the perfused isolated rat tail. Br J Pharmacol. 1970 Jan;38(1):20–36. doi: 10.1111/j.1476-5381.1970.tb10333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Willoughby D. A. Effects of prostaglandins PGF2a and PGE1 on vascular permeability. J Pathol Bacteriol. 1968 Oct;96(2):381–387. doi: 10.1002/path.1700960216. [DOI] [PubMed] [Google Scholar]
- Zurier R. B., Ballas M. Prostaglandin E 1 (PGE 1 ) suppression of adjuvant arthritis. Histopathology. Arthritis Rheum. 1973 Mar-Apr;16(2):251–257. doi: 10.1002/art.1780160218. [DOI] [PubMed] [Google Scholar]